Japan’s Taiho Pharmaceutical agrees to acquire Cullinan Pearl
The transaction also includes a strategic partnership to jointly develop and market Cullinan Oncology’s lead programme, CLN-081/TAS6417, an…
Pfizer to acquire Biohaven Pharmaceuticals in $11.6bn deal
11 May 22The proposed deal includes the acquisition of Biohaven’s calcitonin gene-related peptide (CGRP) programme, including rimegepant, zavegepant and a…
Axsome acquires US rights to Sunosi from Jazz Pharmaceuticals
10 May 22Sunosi is indicated to improve wakefulness in adult patients suffering from excessive daytime sleepiness (EDS) due to narcolepsy…
Samsung Biologics completes acquisition of Samsung Bioepis for $2.3bn
21 Apr 22The acquisition is said to enhance Samsung Bioepis’ business operations, advance its sales growth, improve operating margin, and…
Regeneron to buy cancer therapeutics company Checkmate for $250m
20 Apr 22With the acquisition, Regeneron will obtain Checkmate’s lead candidate vidutolimod, an investigational, advanced generation CpG-A oligodeoxynucleotide Toll-like receptor…
Halozyme to buy speciality pharmaceutical firm Antares Pharma for $960m
14 Apr 22Antares’ commercial products and the current autoinjector expertise will help accelerate Halozyme’s approach to drive durable revenue growth…
GSK agrees to buy Sierra Oncology for $1.9bn
14 Apr 22The proposed acquisition is in line with GSK’s plans to build a strong portfolio of new speciality medicines…
Pfizer to buy biopharmaceutical firm ReViral for $525m
08 Apr 22The proposed acquisition will boost Pfizer’s expertise in infectious disease research and development by providing a complementary approach…
Valo Health acquires TARA Biosystems to create integrated cardiovascular platform
07 Apr 22The transaction will create a vertically integrated platform and cardiovascular disease franchise, which will support the discovery and…
Merck boosts bioprocessing capabilities with MAST platform from Lonza
06 Apr 22The MAST platform provides real-time process information, reduces the process development time by half, and lowers costs